Track And Trace Solutions Market Size and Forecast Overview
The track and trace solutions market is on course to roughly quadruple in under a decade. Moving from USD 3.5 billion in 2022 to USD 14.3 billion by 2030 means revenue grows about 4.1 times over the forecast window. The 19.3% CAGR is steep for an infrastructure-type market, which usually grows more slowly than the products it protects. The market is estimated at USD 4.1 billion in 2023, so the first year of the forecast already adds around USD 0.6 billion.
The main driver is counterfeiting and theft of healthcare products. The WHO estimates that around 10% of all medicines worldwide are counterfeit, and the share rises to 10% to 30% in some African, Asian and Latin American countries. The U.S. Trade Representative’s 2019 report put counterfeit drugs at around 20% of all drugs sold in India. These numbers explain why governments now treat traceability as a compliance requirement rather than an optional upgrade.
Regulation reinforces the demand. In the U.S., the Drug Quality and Security Act requires manufacturers to place a product identifier on each package and case of prescription drugs. Europe’s Falsified Medicines Directive bars manufacturers that fail to meet serialization rules from marketing their products there. In July 2019, Australia’s Therapeutic Goods Administration issued new product-coding guidelines to reduce counterfeiting. COVID-19 then exposed how exposed supply chains were to fake medical products, which pushed traceability up corporate priority lists.
The growth story also has two limits. Implementation cost is high, and there is no unified global standard for serialization and aggregation. Manufacturers selling in several countries must handle different rules and manage complex aggregated data. For buyers, the cost of interoperability may matter as much as the technology itself.
Market projections referenced in this article are drawn from Grand View Research. To explore the data further, try their Prism AI tool.
Key Market Segments in the Track And Trace Solutions Market
The segment picture is clearer when you ask what each layer of the supply chain needs to prove: that a product is real, where it has been, and how its packaging relates to its contents. Each segment answers one of those questions.
Product: Software Leads, Hardware Follows
Software solutions held the largest revenue share in 2022 and are expected to be the most lucrative product segment. Pharmaceutical, biopharmaceutical and medical device companies use them to manage manufacturing facilities, product lines, case and bundle tracking, warehousing and shipping. Vendors are investing in R&D and customer service to stay ahead.
Hardware systems still matter. Within hardware, printing and marking solutions held the largest share in 2021, and they are expected to be central to meeting Drug Supply Chain Security Act requirements. Laser marking, large character marking and thermal transfer overprinting continue to improve coding quality.
Application: Serialization Is the Foundation, Aggregation the Accelerator
Serialization solutions held the largest revenue share in 2022 because regulators are pushing product diversion and counterfeiting controls. Serialization is also the route to ePedigree compliance. Aggregation solutions, which link serialized units to their cases and pallets, are expected to grow at a high rate as healthcare companies adopt them. In practice, many buyers will treat serialization as the entry point and aggregation as the next purchase.
Download a free sample report or claim your copy of this full market intelligence report
Technology: Barcodes Dominate, RFID Grows Faster
Barcode technology held the largest share in 2022, with 2D barcodes the dominant format. They store more data than linear barcodes and are widely used on pharmaceutical packaging. RFID is expected to grow fastest because it is durable, reusable, holds more data and needs no line of sight. The likely outcome is coexistence rather than replacement: barcodes for cost-sensitive packaging, RFID where durability and read speed matter.
End Use and Region: Pharma and North America Set the Pace
Pharmaceutical companies held over 25.0% share in 2022, but consumer packaged goods is expected to show significant growth. Counterfeit goods range from clothing and footwear to batteries, cigarettes and video games, and e-commerce growth has increased counterfeit production. Counterfeit trade in the U.K. was worth 9.3 billion in 2017, according to the Office for National Statistics. That makes CPG the segment to watch beyond healthcare.
Regionally, North America led with over 35.0% share in 2022, helped by strict serialization and aggregation standards and advanced healthcare infrastructure. Europe is the second-largest market and is expected to hold that position through 2030, backed by Germany, Turkey, the U.K., France and Italy.
Key Industry Players in the Track And Trace Solutions Market
Competition is intense because many small and large manufacturers offer tracking and tracing products. Prominent players include Axway, Mettler-Toledo International, Optel Vision, TraceLink, Adents, Antares Vision, Siemens AG, Korber AG, ACG Worldwide and Markem-Imaje, a Dover Company. Their profiles differ: some are software and network specialists, while others bring packaging inspection, marking or industrial automation strengths.
Strategy in this market leans toward partnerships and acquisitions rather than head-on price competition. In January 2022, Optel Group acquired Korber Business Area Pharma’s track and trace unit, known as Taxeed, gaining expertise in agrochemical and pharmaceutical track and trace technologies. In September 2021, Rfxcel, a subsidiary of Antares Vision Group, signed a five-year agreement with the Lebanese Republic’s Ministry of Public Health to provide a GS1-compliant traceability hub for the country’s pharmaceutical supply chain. Together, these deals show vendors competing on regulatory coverage and ecosystem reach as much as on product features.
What This Means for Buyers and Investors
The track and trace solutions market rewards players who can handle regulatory complexity across regions. Compliance-led demand gives pharma a stable base, while CPG and luxury goods offer room to expand. Cost and fragmented standards remain the main obstacles, so solutions that simplify multi-country compliance are likely to win.
Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs
